BRACKEN CHARLES H R

SEC source: 0001712184-21-000073 · wf-form4_161601848194116.xml · derivative · entry 3

BRACKEN CHARLES H R · CIK 0001091974 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Shares · 4,277 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class A common shares or Class C common shares, as the case may be, at settlement.

F1 · price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class A common shares or Class C common shares, as the case may be, at settlement.

F2 · derivative.exercise_date: The Restricted Share Units vest in full on the first anniversary date following the date of grant.

F2 · derivative.expiration_date: The Restricted Share Units vest in full on the first anniversary date following the date of grant.

SEC source: 0001712184-21-000073 · wf-form4_161601848194116.xml · nonDerivative · entry 2

BRACKEN CHARLES H R · CIK 0001091974 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,937

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class A common shares or Class C common shares, as the case may be, at settlement.

SEC source: 0001712184-21-000073 · wf-form4_161601848194116.xml · nonDerivative · entry 1

BRACKEN CHARLES H R · CIK 0001091974 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,590

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class A common shares or Class C common shares, as the case may be, at settlement.

SEC source: 0001570585-21-000036 · wf-form4_161368727441755.xml · derivative · entry 2

BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,925

Underlying: Class C Ordinary Shares · 68,925 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F2 · derivative.exercise_date: The RSUs vest in two equal semi-annual installments on April 1, 2021 and October 1, 2021.

F2 · derivative.expiration_date: The RSUs vest in two equal semi-annual installments on April 1, 2021 and October 1, 2021.

SEC source: 0001570585-21-000036 · wf-form4_161368727441755.xml · derivative · entry 1

BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,462

Underlying: Class A Ordinary Shares · 34,462 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F2 · derivative.exercise_date: The RSUs vest in two equal semi-annual installments on April 1, 2021 and October 1, 2021.

F2 · derivative.expiration_date: The RSUs vest in two equal semi-annual installments on April 1, 2021 and October 1, 2021.

SEC source: 0001570585-20-000335 · wf-form4_160626026965625.xml · nonDerivative · entry 1

BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,658

F1 · price: The price reflects a weighted average of sales made at prices ranging from $22.82 to $22.835. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, information regarding the number of shares purchased at each separate price.

SEC source: 0001712184-20-000300 · wf-form4_160193334815636.xml · derivative · entry 3

BRACKEN CHARLES H R · CIK 0001091974 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class C Common Shares · 5,799 shares

Expires 2020-10-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class C common shares at settlement.

F1 · price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class C common shares at settlement.

SEC source: 0001712184-20-000300 · wf-form4_160193334815636.xml · nonDerivative · entry 1

BRACKEN CHARLES H R · CIK 0001091974 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,942

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class C common shares at settlement.

SEC source: 0001712184-20-000367 · wf-form4a_160712083835728.xml · nonDerivative · entry 1

BRACKEN CHARLES H R · CIK 0001091974 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,383

F1 · shares: The Reporting Person is filing this amendment to reflect the number of shares withheld in payment of taxes.

SEC source: 0001712184-20-000300 · wf-form4_160193334815636.xml · derivative · entry 2

BRACKEN CHARLES H R · CIK 0001091974 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,799

Underlying: Class C Common Shares · 5,799 shares

Expires 2020-10-05

F2 · security: In connection with the Issuer's recently completed rights offering to purchase Class C common shares (LILAK), holders of outstanding share appreciation rights (SARs) to acquire shares of Class A common shares (LILA) or LILAK and holders of outstanding restricted share units (RSUs) or performance-based RSUs relating to shares of LILA or LILAK received a new grant of RSUs relating to shares of LILAK to compensate for the diminution in value associated with the common shares underlying their outstanding SARs, RSUs and performance-based RSUs. These grants of RSUs were approved by the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended.

F1 · derivative.exercise_price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class C common shares at settlement.

F3 · shares: The number of RSUs was determined based, in part, on the volume-weighted average trading price of both LILAK shares and the subscription rights to purchase LILAK shares over the trading days occurring during the subscription period for the rights offering, beginning on and including September 11, 2020 and ending on and including September 25, 2020.

F3 · derivative.underlying_shares: The number of RSUs was determined based, in part, on the volume-weighted average trading price of both LILAK shares and the subscription rights to purchase LILAK shares over the trading days occurring during the subscription period for the rights offering, beginning on and including September 11, 2020 and ending on and including September 25, 2020.

SEC source: 0001570585-20-000290 · wf-form4_160193310395244.xml · derivative · entry 6

BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class C Ordinary Shares · 43,584 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F2 · derivative.exercise_date: The RSUs vest in two equal semi-annual installments on April 1, 2020 and October 1, 2020.

F2 · derivative.expiration_date: The RSUs vest in two equal semi-annual installments on April 1, 2020 and October 1, 2020.

SEC source: 0001570585-20-000290 · wf-form4_160193310395244.xml · derivative · entry 5

BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Ordinary Shares · 21,792 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F2 · derivative.exercise_date: The RSUs vest in two equal semi-annual installments on April 1, 2020 and October 1, 2020.

F2 · derivative.expiration_date: The RSUs vest in two equal semi-annual installments on April 1, 2020 and October 1, 2020.

SEC source: 0001570585-20-000290 · wf-form4_160193310395244.xml · nonDerivative · entry 4

BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,342

SEC source: 0001570585-20-000290 · wf-form4_160193310395244.xml · nonDerivative · entry 3

BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,828

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

SEC source: 0001570585-20-000290 · wf-form4_160193310395244.xml · nonDerivative · entry 2

BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,404

SEC source: 0001570585-20-000290 · wf-form4_160193310395244.xml · nonDerivative · entry 1

BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,648

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

SEC source: 0001712184-20-000236 · wf-form4_160072398101665.xml · derivative · entry 2

BRACKEN CHARLES H R · CIK 0001091974 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class C Common Shares · 7,517 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The rights offering is subject to termination or extension by the Issuer at any time prior to consummation.

F2 · derivative.exercise_date: The rights offering commenced on September 11, 2020.

F3 · derivative.expiration_date: The rights offering will expire at 5:00 p.m., New York City time, on September 25, 2020 unless extended by the Issuer.

SEC source: 0001712184-20-000236 · wf-form4_160072398101665.xml · nonDerivative · entry 1

BRACKEN CHARLES H R · CIK 0001091974 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,143

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001570585-20-000122 · wf-form4_158767723236526.xml · derivative · entry 12

BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 169,960

Underlying: Class C Ordinary Shares · 169,960 shares

Expires 2023-06-24

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing SAR has not changed as a result of the extension and therefore the SAR continues to be immediately exercisable.

SEC source: 0001570585-20-000122 · wf-form4_158767723236526.xml · derivative · entry 11

BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class C Ordinary Shares · 169,960 shares

Expires 2020-06-24

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing SAR has not changed as a result of the extension and therefore the SAR continues to be immediately exercisable.

SEC source: 0001570585-20-000122 · wf-form4_158767723236526.xml · derivative · entry 10

BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 339,754

Underlying: Class C Ordinary Shares · 339,754 shares

Expires 2023-06-24

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing SAR has not changed as a result of the extension and therefore the SAR continues to be immediately exercisable.

SEC source: 0001570585-20-000122 · wf-form4_158767723236526.xml · derivative · entry 9

BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class C Ordinary Shares · 339,754 shares

Expires 2020-06-24

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing SAR has not changed as a result of the extension and therefore the SAR continues to be immediately exercisable.

SEC source: 0001570585-20-000122 · wf-form4_158767723236526.xml · derivative · entry 8

BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,435

Underlying: Class C Ordinary Shares · 37,435 shares

Expires 2023-05-01

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing SAR has not changed as a result of the extension and therefore the SAR continues to be immediately exercisable.

SEC source: 0001570585-20-000122 · wf-form4_158767723236526.xml · derivative · entry 7

BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class C Ordinary Shares · 37,435 shares

Expires 2020-05-01

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing SAR has not changed as a result of the extension and therefore the SAR continues to be immediately exercisable.

SEC source: 0001570585-20-000122 · wf-form4_158767723236526.xml · derivative · entry 6

BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,888

Underlying: Class C Ordinary Shares · 74,888 shares

Expires 2023-05-01

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing SAR has not changed as a result of the extension and therefore the SAR continues to be immediately exercisable.

SEC source: 0001570585-20-000122 · wf-form4_158767723236526.xml · derivative · entry 5

BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class C Ordinary Shares · 74,888 shares

Expires 2020-05-01

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing SAR has not changed as a result of the extension and therefore the SAR continues to be immediately exercisable.

SEC source: 0001570585-20-000122 · wf-form4_158767723236526.xml · derivative · entry 4

BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 170,684

Underlying: Class A Ordinary Shares · 170,684 shares

Expires 2023-06-24

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing SAR has not changed as a result of the extension and therefore the SAR continues to be immediately exercisable.

SEC source: 0001570585-20-000122 · wf-form4_158767723236526.xml · derivative · entry 3

BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Ordinary Shares · 170,684 shares

Expires 2020-06-24

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing SAR has not changed as a result of the extension and therefore the SAR continues to be immediately exercisable.

SEC source: 0001570585-20-000122 · wf-form4_158767723236526.xml · derivative · entry 2

BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,610

Underlying: Class A Ordinary Shares · 37,610 shares

Expires 2023-05-01

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing SAR has not changed as a result of the extension and therefore the SAR continues to be immediately exercisable.

SEC source: 0001570585-20-000122 · wf-form4_158767723236526.xml · derivative · entry 1

BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Ordinary Shares · 37,610 shares

Expires 2020-05-01

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share appreciation rights (SAR) for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding SAR were to be cancelled and replaced by a new SAR. However, from the Issuer's perspective, no new SAR is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing SAR has not changed as a result of the extension and therefore the SAR continues to be immediately exercisable.

SEC source: 0001570585-20-000096 · wf-form4_158594861889669.xml · derivative · entry 10

BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 354,766

Underlying: Class C Ordinary Shares · 354,766 shares

Expires 2030-04-01

F4 · derivative.exercise_date: The Share Appreciation Rights vest in three equal annual installments commencing on May 1, 2021.

SEC source: 0001570585-20-000096 · wf-form4_158594861889669.xml · derivative · entry 9

BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 177,383

Underlying: Class A Ordinary Shares · 177,383 shares

Expires 2030-04-01

F4 · derivative.exercise_date: The Share Appreciation Rights vest in three equal annual installments commencing on May 1, 2021.

SEC source: 0001570585-20-000096 · wf-form4_158594861889669.xml · derivative · entry 8

BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 147,976

Underlying: Class C Ordinary Shares · 147,976 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F3 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on May 1, 2021.

F3 · derivative.expiration_date: The RSUs vest in three equal annual installments commencing on May 1, 2021.

SEC source: 0001570585-20-000096 · wf-form4_158594861889669.xml · derivative · entry 7

BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,988

Underlying: Class A Ordinary Shares · 73,988 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F3 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on May 1, 2021.

F3 · derivative.expiration_date: The RSUs vest in three equal annual installments commencing on May 1, 2021.

SEC source: 0001570585-20-000096 · wf-form4_158594861889669.xml · derivative · entry 6

BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,584

Underlying: Class C Ordinary Shares · 43,583 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F2 · derivative.exercise_date: The RSUs vest in two equal semi-annual installments on April 1, 2020 and October 1, 2020.

F2 · derivative.expiration_date: The RSUs vest in two equal semi-annual installments on April 1, 2020 and October 1, 2020.

SEC source: 0001570585-20-000096 · wf-form4_158594861889669.xml · derivative · entry 5

BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,792

Underlying: Class A Ordinary Shares · 21,792 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F2 · derivative.exercise_date: The RSUs vest in two equal semi-annual installments on April 1, 2020 and October 1, 2020.

F2 · derivative.expiration_date: The RSUs vest in two equal semi-annual installments on April 1, 2020 and October 1, 2020.

SEC source: 0001570585-20-000096 · wf-form4_158594861889669.xml · nonDerivative · entry 4

BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,244

SEC source: 0001570585-20-000096 · wf-form4_158594861889669.xml · nonDerivative · entry 3

BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,729

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

SEC source: 0001570585-20-000096 · wf-form4_158594861889669.xml · nonDerivative · entry 2

BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,856

SEC source: 0001570585-20-000096 · wf-form4_158594861889669.xml · nonDerivative · entry 1

BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,100

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

SEC source: 0001712184-20-000118 · wf-form4_158595019856619.xml · derivative · entry 6

BRACKEN CHARLES H R · CIK 0001091974 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class C Common Shares · 4,168 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class A common shares or Class C common shares, as the case may be, at settlement.

F1 · price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class A common shares or Class C common shares, as the case may be, at settlement.

F2 · derivative.exercise_date: The Restricted Share Units vest in full on the first anniversary date following the date of grant.

F2 · derivative.expiration_date: The Restricted Share Units vest in full on the first anniversary date following the date of grant.

SEC source: 0001712184-20-000118 · wf-form4_158595019856619.xml · derivative · entry 5

BRACKEN CHARLES H R · CIK 0001091974 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Shares · 2,084 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class A common shares or Class C common shares, as the case may be, at settlement.

F1 · price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class A common shares or Class C common shares, as the case may be, at settlement.

F2 · derivative.exercise_date: The Restricted Share Units vest in full on the first anniversary date following the date of grant.

F2 · derivative.expiration_date: The Restricted Share Units vest in full on the first anniversary date following the date of grant.

SEC source: 0001712184-20-000118 · wf-form4_158595019856619.xml · nonDerivative · entry 4

BRACKEN CHARLES H R · CIK 0001091974 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,626

SEC source: 0001712184-20-000118 · wf-form4_158595019856619.xml · nonDerivative · entry 3

BRACKEN CHARLES H R · CIK 0001091974 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,846

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class A common shares or Class C common shares, as the case may be, at settlement.

SEC source: 0001712184-20-000118 · wf-form4_158595019856619.xml · nonDerivative · entry 2

BRACKEN CHARLES H R · CIK 0001091974 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,313

SEC source: 0001712184-20-000118 · wf-form4_158595019856619.xml · nonDerivative · entry 1

BRACKEN CHARLES H R · CIK 0001091974 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,423

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class A common shares or Class C common shares, as the case may be, at settlement.

SEC source: 0001712184-20-000074 · wf-form4_158448089051473.xml · derivative · entry 2

BRACKEN CHARLES H R · CIK 0001091974 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,554

Underlying: Class C Common Shares · 8,554 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class A common shares or Class C common shares, as the case may be, at settlement.

F1 · price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class A common shares or Class C common shares, as the case may be, at settlement.

F2 · derivative.exercise_date: The Restricted Share Units vest in full on the first anniversary date following the date of grant.

F2 · derivative.expiration_date: The Restricted Share Units vest in full on the first anniversary date following the date of grant.

SEC source: 0001712184-20-000074 · wf-form4_158448089051473.xml · derivative · entry 1

BRACKEN CHARLES H R · CIK 0001091974 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,277

Underlying: Class A Common Shares · 4,277 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class A common shares or Class C common shares, as the case may be, at settlement.

F1 · price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class A common shares or Class C common shares, as the case may be, at settlement.

F2 · derivative.exercise_date: The Restricted Share Units vest in full on the first anniversary date following the date of grant.

F2 · derivative.expiration_date: The Restricted Share Units vest in full on the first anniversary date following the date of grant.

SEC source: 0001570585-20-000059 · wf-form4_158327410630775.xml · derivative · entry 6

BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class C Ordinary Shares · 1,078 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Share Unit represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F1 · price: Each Restricted Share Unit represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F2 · derivative.exercise_date: The RSUs vest in full on March 1, 2020.

F2 · derivative.expiration_date: The RSUs vest in full on March 1, 2020.

SEC source: 0001570585-20-000059 · wf-form4_158327410630775.xml · derivative · entry 5

BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Ordinary Shares · 539 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Share Unit represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F1 · price: Each Restricted Share Unit represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F2 · derivative.exercise_date: The RSUs vest in full on March 1, 2020.

F2 · derivative.expiration_date: The RSUs vest in full on March 1, 2020.